Immuno-PET developer ImaginAB and radiology artificial intelligence (AI) software developer Quibim will collaborate on technology for use in immunotherapy treatment.
ImaginAB is developing a zirconium-89 (Zr-89) crefmirlimab berdoxam PET imaging radiotracer (CD8 ImmunoPET) for use in patients undergoing cancer immunotherapy treatment. Under the agreement, Quibim will develop an imaging-based algorithm to interpret CD8 ImmunoPET PET/CT scans to potentially help clinicians monitor the effectiveness of treatments.
